Commission Implementing Regulation (EU) 2025/2074 of 16 October 2025 granting a Union authorisation for the biocidal product family B. Braun Medical Propanol Family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

A Union authorisation with authorisation number EU-0033840-0000 is granted to B. Braun Medical AG for the making available on the market and use of the biocidal product family ‘B. Braun Medical Propanol Family’ subject to compliance with the terms and conditions set out in Annex I and in accordance with the summary of the biocidal product characteristics set out in Annex II. The Union authorisation is valid from 9 November 2025 until 31 October 2035.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.